Changes in the prevalence of hepatitis C virus genotype among Italian injection drug users-Relation to period of injection started

Journal of Clinical Virology

Volumn 45, Issue 4, 2009, Pages 354-357

  Sereno, Silvia ^a   Perinelli, Paola ^a   Laghi, Vittorio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Epidemiology; Genotype; HCV; IVDU

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ITALY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; VIRUS STRAIN;

ADULT; DRUG USERS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; ITALY; MALE; MIDDLE AGED; PREVALENCE; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 67649641782     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.04.022     Document Type: Article

References (39)

1. Lauer G., and Walker B.D. Hepatitis C virus infection. N Engl J Med 345 (2001) 41-52
2. Wasley A., and Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20 (2000) 1-16
3. Shepard C.W., Finelli L., and Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5 (2005) 558-567
4. Zein N.N. Clinical significance of hepatitis C virus genotypes. Clin Microb Rev 13 (2000) 223-235
5. Esteban J., Sauleda S., and Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 48 (2008) 148-162
6. Bellentania S., Miglioria L., Masuttib F., Saccoccia G., and Tiribellib C. Epidemiology of hepatitis C virus infection in Italy: the slowly unravelling mystery. Microb Infect 2 (2000) 1757-1763
7. Ansaldi F., Bruzzone B., Salmaso S., Rota M.C., Durando P., Gasparini R., et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 76 (2005) 327-332
8. Busch M.P. Closing the windows on viral transmission by blood transfusion. In: Stramer S.L. (Ed). Blood safety in the new millennium (2001), American Association of Blood Banks, Bethesda 33-54
9. Trepo C., and Pradat P. Hepatitis C virus infection in Western Europe. J. Hepatol 31 Suppl. 1 (1999) 80-83
10. Edlin B.R., and Carden M.R. Injection drug users: the overlooked core of the hepatitis C epidemic. Clin Infect Dis 42 (2006) 673-676
11. Mathei C., Buntinx F., and van Damme P. Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review. J Viral Hepat 9 (2002) 157-173
12. Simmonds P., McOmish F., Yap P.L., Chan S.W., Lin K., Dusheiko G., et al. Classification of hepatitis C virus into six major genotypes and series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74 (1993) 2391-2399
13. NIH consensus guidelines management of hepatitis C (2002), National Institutes of Health p. 1-43
14. Lucidarme D., Foutrein P., and Creusy C. Prevalence des marquers de l'hepatite C, B et D et aspects histopathologiques dans un groupe de toxicomanes intraveneux. Gastroenterol Clin Biol 18 (1994) 964-968
15. Sarracco G., Sostegni R., Ghisetti V., Rocca G., Cariti G., Andreoni M., et al. Hepatitis C virus genotypes in a non-cirrhotic Italian population with chronic hepatitis C: correlation with clinical, virological and histological parameters. Results of a prospective multicentre study. J Viral Hepat 7 (2000) 124-129
16. Matera G., Lamberti A., Quirino A., Foca D., Giancotti A., Barreca G.S., et al. Changes in the prevalence of hepatitis C virus (HCV) genotype 4 in Calabria, Southern Italy. Diagn Microbiol Infect Dis 42 (2002) 169-173
17. Dal Molin G., Ansaldi F., Biagi C., D'Agaro P., Comar M., Croce L., et al. Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. J Med Virol 68 (2002) 352-356
18. Sereno S., Cenci M., Recchia O., and Laghi V. Hepatitis C virus infection in Italy: a dynamic event. e-GUT (2005) gut.bmj.com/cgi/eletters/54/6/852
19. van de Laar T.J., Koppelman M.H., van der Bij A.K., Zaaijer H.L., Cuijpers H.T., Van der Poel C.L., et al. Diversity and origin of hepatitis C virus infection among unpaid blood donors in the Netherlands. Transfusion 46 (2006) 1719-1728
20. Stroffolini T., Fiume A., Fatale G., Regni F., Ciccozzi M., Marzolini A., et al. Hepatitis C virus genotypes among intravenous drug users in Italy. Hepatol Res 9 (1997) 20-27
21. Kamal S.M., and Nasser I.A. Hepatitis C genotype 4: what we know and what we don't yet know. Hepatology 47 (2008) 1371-1383
22. Chlabicz S., Flisiak R., Kowalczuk O., Wierciń ska-Drapalo A., Pytel-Krolczuk B., Prokopowicz D., et al. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland. J Med Virol 80 (2008) 615-618
23. Rapicetta M., Argentini C., Dettori S., Spada E., Pellizzer G., and Gandin C. Molecular heterogeneity and new subtypes of HCV genotype 4. Res Virol 149 (1998) 293-297
24. Roulot D., Bourcier V., Grando V., Deny P., Baazia Y., Fontaine H., et al. Observational VHC4 Study Group. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. J Viral Hepat 14 (2007) 460-467
25. Smith D.B., Pathirana S., Davidson F., Lawlor E., Power J., Yap P.L., et al. The origin of hepatitis C virus genotypes. J Gen Virol 78 (1997) 321-328
26. Verbeeck J., Maes P., Lemey P., Pybus O.G., Wollants E., Song E., et al. Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol 80 (2006) 4220-4226
27. Giannini C., Giannelli F., Monti M., Caroccia G., Marrocchi M.E., Laffi G., et al. Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease. J Lab Clin Med 134 (1999) 68-73
28. Bowden S., McCaw R., White P.A., Crofts N., and Aitken C.K. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. J Viral Hepat 12 (2005) 322-324
29. Herring B.L., Page-Shafer K., Toble L.H., and Delwart E.L. Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis 190 (2004) 1396-1403
30. Mathei C., Wollants E., Verbeeck J., van Ranst M., Robaeys G., van Damme P., et al. Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours. Eur J Clin Microbiol Infect Dis 24 (2005) 513-522
31. Silini E., Bono F., Cividini A., Cerino A., Maccabruni A., Tinelli C., et al. Molecular epidemiology of Hepatitis C virus infection among intravenous drug users. J Hepatol 22 (1995) 691-695
32. Micalessi M., Gérard C., Ameye L., Plasschaert S., Brochier B., and Vranckx R. Distribution of Hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005. J Med Virol 80 (2008) 640-645
33. Ross R.S., Viazov S., Renzing-Koholer K., and Roggendorf M. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes. J Med Virol 60 (2000) 122-125
34. Payan C., Roudot-Thoraval F., Marcellin P., Bled N., Duverlie G., Fouchard-Hubert I., et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millennium: the GEMHEP GenoCII Study. J Viral Hepat 12 (2005) 405-413
35. Savvas S.P., Koskinas J., Sinani C., Hadziyannis A., Spanou F., and Hadziyannis S.J. Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece. J Viral Hepat 12 (2005) 551-557
36. Cenci M., Massi M., Alderisio M., De Soccio G., and Recchia O. Prevalence of hepatitis C virus (HCV) genotypes and increase of type 4 in central Italy: an update and report of a new method of HCV genotyping. Anticancer Res 27 (2007) 1219-1312
37. Bourliere M., Barberin J.M., Rotily M., Guagliardo V., Portal I., and Lecomte L. Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. J Viral Hepat 9 (2000) 62-70
38. Kalinina O., Norder H., Vetrov T., Zhdanov K., Barzunova M., Plotnikova V., et al. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J Med Virol 65 (2001) 517-524
39. Chlabicz S., Flisiak R., Kowalczuk O., Grzeszczuk A., Pytel-Krolczuk B., Prokopowicz D., et al. Changing HCV genotypes distribution in Poland-relation to source and time of infection. J Clin Virol 42 (2008) 156-159